The Pulse: Health and benefits updates

Healthcare cost transparency reveals actual negotiated prices instead of carrier discounts, creating a clearer view for evaluating pricing, fees and quality.

Novo Nordisk slashed list prices for GLP-1 drugs by up to 50% starting January 2027, but existing rebates mean employer net costs likely won't change. High-deductible plan members may benefit most.

Federal actions on PBMs include FTC insulin settlement, Break Up Big Medicine Act and DOL disclosure rules. These aim to increase transparency, lower drug costs and give plan sponsors more leverage.

Empowering organizations to build cultures where mental health is prioritized, stigma is reduced and employees can thrive.

Expert MHPAEA compliance services: plan evaluation, risk mitigation and DOL audit support. Litigation-ready solutions for employers.

We partner with you to build an effective employee benefits program that sustains a healthy, high-performing workforce.

We unlock the business value of employee wellbeing, boosting the effectiveness of total rewards, increasing employee engagement, and improving work-life balance, performance and productivity.

Our pharmacy benefits consulting team includes pharmacists, actuaries, and pricing experts who bring deep expertise in managing the complexities of pharmacy benefits.

Improve employee health and reduce healthcare costs by treating members with digestive health conditions